People

Sanjay Mistry

Johnson & Johnson Innovation–JJDC venture investor focused on new company creation. TRexBio director as of October 5, 2026, with resignation planned before IPO registration effectiveness; previously worked at Quaker Partners and in J&J research, operations and venture creation.